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Nigella sativa seed, commonly known as black seed, has been employed as a natural remedy for many ailments for centuries in many
cultures. It contains many active components including thymoquinone, thymohydroquinone, dithymoquinone, thymol, carvacrol, nigel-
limine, nigellicine, nigellidine and alphahederin. It was reported to possess numerous pharmacological eﬀects related to several organs of
the body. In this article, the literature pertaining to dermatological eﬀects of N. sativa is reviewed. To the best of our knowledge this is the
ﬁrst review in this subject and we expect it stimulates further studies on the dermatological eﬀects and application of N. sativa.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Nigella sativa (N. sativa) belongs to the botanical family
of Ranunculaceae and commonly grows in the Eastern
Europe, Middle East, and Western Asia. It is a small shrub
with tapering green leaves and rosaceous white and pur-
plish ﬂowers. Its ripe fruit contains tiny seeds, dark black
in color, known as “Habba Al-Sauda” or “Habba
Al-Barakah” in Arabic and black seed in English. The seed
and oil of N. sativa were frequently used in ancient reme-
dies (Unani, Ayurveda, Chinese and Arabic) in Asian
countries and in the middle east. Several uses of the N.
sativa seed had been mentioned by Ibne-Sina (980–1037)
in his famous book Al-Qanoon ﬁ el-Tibb (El-Kadi and
Kandil, 1986; Al-Jishi, 2000).
Numerous active components have been isolated from
N. sativa seed and its oil including thymoquinone,
thymohydroquinone, dithymoquinone, thymol, carvacrol,
nigellimine-N-oxide, nigellicine, nigellidine and
alpha-hederin. The pharmacological properties of N.
sativa and its ingredients had been investigated by
in vitro and in vivo studies conducted on human and lab-
oratory animals. These studies showed that N. sativa and
its ingredients have a wide range of pharmacological
eﬀects; immune-stimulatory, anti-inﬂammatory, hypo-
glycemic, antihypertensive, antiasthmatic, antimicrobial,
antiparasitic, antioxidant and anticancer eﬀects (reviewed
in Randhawa and Alghamdi, 2002, 2011; Ali and
Blunden, 2003; Salem, 2005; Padhye et al., 2008;
Randhawa, 2008). Acute and chronic toxicity studies on
laboratory animals have reported that N. sativa seed, its
oil and thymoquinone, the most abundant and widely
studied active principle, are safe, particularly when given
orally (Badary et al., 1998; Mansour et al., 2001; Al-Ali
et al., 2008). The objective of this article is to review
the reported dermatological eﬀects of N. sativa. An online
and PubMed search of published articles related to the
dermatological eﬀects of N. sativa seed, its oil and active
ingredients was conducted. Only articles substantiated by
appropriate scientiﬁc methodology were reviewed and
included. The following are categories of the studies:
antimicrobial, antiviral, antifungal, antiparasitic, wound
healing, psoriasis, acne vulgaris, vitiligo, skin cancer,
percutaneous absorption, cosmetic application and
cutaneous side eﬀects.2. Antimicrobial eﬀects
2.1. Antibacterial
Topozada et al. (1965) were ﬁrst to report the antibacte-
rial eﬀect of the phenolic fraction of N. sativa oil.
El-Fatatry (1975) isolated thymohydroquinone from the
volatile oil of N. sativa, which was found to have high
activity against gram-positive microorganisms, including
Staphylococcus aureus. Diethyl-ether extract of N. sativa
was reported to possess concentration dependent inhibitory
eﬀect on gram-positive bacteria (represented by S. aureus)
and gram-negative bacteria (represented by Pseudomonas
aeruginosa and Escherichia coli) (Hanaﬁ and Hatem,
1991). It also showed synergistic eﬀect with streptomycin
and gentamycin and additive eﬀect with spectinomycin,
erythromycin, tobramycin, doxycycline, chloramphenicol,
nalidixic acid, ampicillin, lincomycin and co-trimoxazole
and successfully eradicated a non-fatal subcutaneous
staphylococcal infection induced experimentally in mice
when injected at the site of infection (Hanaﬁ and Hatem,
1991). N. sativa extract showed almost similar results to
topical mupirocin in the treatment of neonates with staphy-
lococcal pustular skin infections with no side eﬀects (Rafati
et al., 2014). Microbial resistance to drugs is a common and
important issue. Studies of the eﬀects of N. sativa extracts
in vitro against resistant microorganisms, including resis-
tant S. aureus and P. aeruginosa, showed promising and
good results against many multi-drug-resistant gram posi-
tive and gram negative bacteria (Morsi, 2000;
Mashhadian and Rakhshandeh, 2005; Salman et al., 2005).2.2. Antiviral
N. sativa was found to enhance helper T cell (T4) and
suppressor T cell (T8) ratio and increased natural killer
(NK) cell activity in healthy volunteers (El-Kadi and
Kandil, 1986). Besides improvement in immunity, N. sativa
extract had some inhibitory eﬀect on the human immune
deﬁciency virus protease but the active principle(s) respon-
sible for this activity was not identiﬁed (Ma et al., 1994).
Moreover, N. sativa oil when given intraperitoneally to
mice infected with murine cytomegalovirus for 10 days,
the virus was undetectable in the liver and spleen, while it
was still detectable in the control mice. This action was
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function of M-phi and CD4 +ve T cells and increased
production of INF-gamma (Salem and Hossain, 2000).2.3. Antifungal
Hanaﬁ and Hatem (1991) were the ﬁrst to demonstrate
the inhibitory eﬀect of the diethyl-ether extract of N. sativa
extract against Candida albicans. The ether extract of N.
sativa was reported to inhibit the growth of Candida yeasts
in several organs in experimental animal infections (Khan
et al., 2003). Thymoquinone was also shown to inhibit
in vitro Aspergillus niger and Fusarium solani and the activ-
ity was comparable to amphotericin-B (Al-Jabre et al.,
2003; Alqorashi et al., 2007; Randhawa et al., 2005). It
was reported to be more eﬀective than amphotericin-B
and griseofulvin against Scopulariopsis brevicaulis growth
in vitro. There was 100% inhibition of the growth of S. bre-
vicaulis with thymoquinone 1 mg/ml, while amphotericin-B
1 mg/ml inhibited only 70% growth. However, clotrimazole
was much more eﬀective than the above mentioned drugs,
with an MIC of 0.03 mg/ml (Aljabre, 2005).
The ether extract of N. sativa was found to inhibit der-
matophytes isolated from sheep skin infection (Kader
et al., 1995). Thymoquinone was shown to possess moder-
ate activity against clinical isolates of the three main groups
of dermatophytes: Trichophyton, Epidermophyton and
Microsporum and the ether extract of N. sativa were also
found to be eﬀective but in relatively higher concentrations
(Aljabre et al., 2005). The MIC of thymoquinone against
various dermatophytes ranged from 0.125 to 0.25 mg/ml,
while the ether extract inhibited 80–100% of the growth
of most dermatophytes at 40 mg/ml. Proportionately,
greater eﬀect of thymoquinone than N. sativa extract points
out to that, the antifungal activity of N. sativa is primarily
due to thymoquinone (Aljabre et al., 2005). In another
study also thymoquinone, thymohydroquinone and thymol
demonstrated antifungal eﬀect against many clinical iso-
lates, including dermatophytes, molds and yeasts at a con-
centration of 1 mg/ml (Taha et al., 2010). Using broth
microdilution assay, extract of N. sativa inhibited the
growth of Madurella mycetomatis, an important causative
fungus of mycetoma, at a concentration as low as 1 lg/ml
(Elfadil et al., 2015).2.4. Antiparasitic
An ointment prepared from the alcoholic extract of N.
sativa seeds was applied daily for 15 weeks to cutaneous
leishmaniasis produced experimentally in mice by a subcu-
taneous inoculation of Leishmania major at the dorsal base
of the tail. The morphology of the lesion and the body
weight of mice were monitored daily. There was no signif-
icant diﬀerence between the average weight of mice receiv-
ing N. sativa extract ointment and controls but the lesion
diameter and symptoms of inﬂammation were signiﬁcantlylesser in the test group as compared to the controls (Bafghi
et al., 2011).
N. sativa seed was tested against miracidia, cercariae
and adult worms of Schistosoma mansoni and showed
strong biocidal activity against all stages of the parasite,
as well as an inhibitory eﬀect on egg-laying of adult female
worms, indicating an antischistosomal potential of the N.
sativa (Mohamed et al., 2005). In S. mansoni experimen-
tally infected mice, the antischistosomal activity of N.
sativa oil was found to be comparable to praziquantel
and when given in combination with praziquantel there
was potentiation of its eﬀect (Mahmoud et al., 2002).
3. Wound healing
N. sativa seed and its oil were found to promote wound
healing in farm animals (Ahmed et al., 1995). Moreover,
ether extract of N. sativa seed applied topically onto
staphylococcal-infected skin in mice enhanced healing by
reducing total and absolute diﬀerential WBC counts, local
infection and inﬂammation, bacterial expansion and tissue
impairment (Abu-Al-Basal, 2011). Using human gingival
ﬁbroblast as a monolayer, aqueous extract of N. sativa
exhibited low free radical scavenging activity and induced
gingival ﬁbroblast proliferation with accelerated wound
closure activity despite its non-signiﬁcant eﬀect on collagen
synthesis (Ab Rahman et al., 2014). It also resulted in ele-
vation of basic ﬁbroblast growth factor and transforming
growth factor beta (Ab Rahman et al., 2014).
4. Anti-inﬂammatory
4.1. Psoriasis
The ethanolic extract of N. sativa seed was evaluated for
antipsoriatic activity in vivo by using mouse tail model for
psoriasis and in vitro by using sulforhodamine B assay
employing HaCaT human keratinocyte cell lines
(Dwarampudi et al., 2012).
Signiﬁcant epidermal diﬀerentiation was produced by the
ethanolic extract ofN. sativa, 71.36 ± 2.64%. In the negative
control the epidermal diﬀerentiation was 17.30 ± 4.09% and
in the positive control (tazarotene 0.1%) was 90.03 ± 2.00%.
The antiproliferant activity of the ethanolic extract of N.
sativa was good, IC50 value of 239 lg/ml, as compared to
that of the positive control, asiaticoside, which showed
potent activity with IC50 value of 20.13 lg/ml.
4.2. Acne vulgaris
In a clinical study (Abdul-Ameer and Al-Harchan, 2010),
N. sativa oil lotion 10% signiﬁcantly reduced mean lesion
count of papules and pustules after 2 months of therapy. In
the test group, the response to treatment was graded as good
in 58%,moderate in 35% and no response in 7%. The satisfac-
tion of patients with treatment was found to be full in 67%,
partial in 28%, and no satisfaction in 5%.While in the control
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2 months and the response to treatmentwas good in8%,mod-
erate in 34%, and no response in 58%. The satisfaction of
patients with treatment in this group was full in 8%, partial
in 24%, and no satisfaction in 68%. There were no side eﬀects
in the group treatedwithN. sativa oil lotion 10%.The authors
attributed the results to the antimicrobial, immunomodula-
tory and anti-inﬂammatory eﬀects ofN. sativa oil. Themolec-
ular mechanisms of anti-inﬂammatory and antioxidative
activities of thymoquinone, the most abundant active
principle of N. sativa had been studied. Pretreatment of
female HR-1 hairless mouse skin with thymoquinone attenu-
ated 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced
expression of cyclooxygenase-2 (COX-2). Thymoquinone
diminished nuclear translocation and the DNA binding of
nuclear factor-kappa-B (NF-jB) via the blockade of phos-
phorylation and subsequent degradation of IjBa in
TPA-treated mouse skin. Thymoquinone also attenuated
the phosphorylation of Akt, c-Jun-N-terminal kinase and
p38mitogen-activatedproteinkinase, butnot that of extracel-
lular signal-regulated kinase-1/2. Moreover, topical applica-
tion of thymoquinone induced the expression of
hemeoxygenase-1, NAD(P)H-quinoneoxidoreductase-1,
glutathione-S-transferase and glutamate cysteine ligase in
mouse skin (Kundu et al., 2013).
Similar anti-inﬂammatory eﬀect of N. sativa ﬁxed oil
and thymoquinone has also been reported earlier by
Houghton et al. (1995). The eﬀect was demonstrated via
the dose-dependent decrease in the formation of thrombox-
ane B2 and leukotriene B4 showing the inhibition of
cyclooxygenase and 5-lipooxygenase pathways of arachi-
donate metabolism in rat peritoneal leukocytes.
5. Skin pigmentation
5.1. Vitiligo
Lyophilized seed extract of N. sativa and its active ingre-
dient, thymoquinone, showed signiﬁcant skin darkening on
the isolated melanophores of the wall lizard (Ali andMeitei,
2011). The pigment cells when exposed to the extract or thy-
moquinone responded by distinct dispersion of melanin
leading to skin darkening. The melanin dispersal eﬀect
was antagonized by anticholinergic drugs, atropine and
hyoscine, and potentiated by an anticholinesterase agent,
neostigmine. The authors suggested that cholinergic mech-
anisms of muscarinic nature are involved in the melanin dis-
persion (Ali and Meitei, 2011). In a randomized double
blind clinical study, patients applied N. sativa oil to lesions
of vitiligo twice daily for 6 months had a signiﬁcant
decrease in the vitiligo area scoring index with no signiﬁcant
side eﬀects (Ghorbanibirgani et al., 2014).
6. Hypersensitivity reactions
Earlier, carbonyl fraction of N. sativa and its active
components, thymoquinone and nigellone were shown tocounter the manifestations of allergic reactions; inhibition
of histamine release from mast cells (Chakravorty, 1993),
protection from histamine-induced bronchospasm in gui-
nea pigs (El-Dakhakhany, 1982) and decreases in the lung
eosinophilia, elevated Th2 cytokines and raised IgE and
IgG1 antibodies in a mouse model of allergic asthma
induced by ovalbumin (El Gazzar et al., 2006).
Recently, a clinical study was conducted to compare the
eﬃcacy of Nigella, Betamethasone and Eucerin ointments
applied topically twice daily for 4 weeks in new cases of
hand eczema. Changes in the severity of eczema and life
quality were assessed by hand eczema severity index
(HECSI) and dermatology life quality index (DLQI),
respectively. Nigella and Betamethasone showed rapid
improvement in the hand eczema and the quality of life
as compared to Eucerin. No signiﬁcant diﬀerence was
detected in the mean HECSI and DLQI scores of the N.
sativa and Betamethasone groups, indicating to the possi-
bility that, N. sativa had same eﬃcacy as Betamethasone
in the improvement of hand eczema and life quality
(Youseﬁ et al., 2013).
7. Skin cancers
The anticancer activity of N. sativa was revealed, for the
ﬁrst time, when an enhancement of the natural killer (NK)
cell activity was observed in advanced cancer patients
receiving multimodality immunotherapy program in which
N. sativa seed was one of the components (El-Kadi and
Kandil, 1986). Regarding dermatology, Salomi et al.
(1991) were ﬁrst to investigate the antineoplastic eﬀect of
N. sativa. They reported that the topical application of
N. sativa and Crocus sativus extracts inhibited two-stage
initiation/promotion of [dimethylbenz [a] anthracene
(DMBA)/croton oil] induced skin carcinogenesis in mice,
delayed the onset of papilloma formation and reduced
the number of papillomas per mouse. Later, the protective
eﬀect of bee honey and Nigella was studied on the oxidative
stress and carcinogenesis induced by methylnitrosourea
(MNU) in Sprague Dawely rats. It was observed that
MNU produced oxidative stresses ranging from severe
inﬂammatory reaction in lung and skin to colon adenocar-
cinoma in four out of six animals. The serum malondialde-
hyde (MDA) and nitric oxide (NO) were also raised.
Treatment with N. sativa seed given orally protected
against MNU-induced oxidative stress and carcinogenesis
by 80% (12/15), whereas honey and N. sativa seed together
protected 100% (12/12); and serum MDA and NO also
signiﬁcantly decreased in both cases compared to active
controls (Mabrouk et al., 2004).
In another study, antineoplastic activity of thymo-
quinone was investigated using mouse keratinocytes, papil-
loma (SP-1) and spindle-17 carcinoma cells. In SP-1 cells
thymoquinone induced G0/G1 cell-cycle arrest, which
correlated with sharp increases in the expression of the
cyclin-dependent kinase inhibitor p16 and a decrease in
cyclin D1 protein expression. While in spindle 17 cells,
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with an increase in the expression of the tumor suppressor
protein p53 and a decrease in cyclin B1 protein. At longer
times of incubation, thymoquinone induced apoptosis in
both cell lines by remarkably increasing the ratio of
Bax/Bcl-2 protein expression and decreasing Bcl-xL pro-
tein. These ﬁndings support a potential role for thymo-
quinone as a chemopreventive agent, particularly at the
early stages of skin tumorigenesis (Gali-Muhtasib et al.,
2004). Antitumor activity of thymoquinone and thymohy-
droquinone was also demonstrated using tumor cell lines
(squamous cell carcinoma, SCC VII) and ﬁbrosarcoma,
FsaR) and murine tumor models of ﬁbrosarcoma and
squamous cell carcinoma (Ivankovic et al., 2006).
Thymoquinone and diosgenin, the active ingredients
obtained from N. sativa and fenugreek (Trigonella foenum-
graecum), respectively, were shown to exert potent bioac-
tivity against squamous cell carcinoma in vitro. They
inhibited cell proliferation and induced cytotoxicity in
A431 and Hep2 cells. These agents induced apoptosis by
increasing the sub-G1 population, LIVE/DEAD cytotoxic-
ity, chromatin condensation, DNA laddering and
TUNEL-positive cells. There was also an increase in
Bax/Bcl-2 ratio, activation of cell proliferation of caspases
and cleavage of poly ADP ribose polymerase in the treated
cells. In combination, thymoquinone and diosgenin had
synergistic eﬀects, resulting in cell viability as low as 10%.
In a mouse xeno-graft model, a combination of thymo-
quinone and diosgenin signiﬁcantly reduced tumor volume,
mass and increased apoptosis (Das et al., 2012).
Using an in vitro cell migration assay, Ahmad et al.
(2013) found that, thymoquinone inhibited the migration
of both human and mouse melanoma cells. The inhibition
of metastasis by thymoquinone was also observed in vivo in
B16F10 mouse melanoma model and was accompanied by
a decrease in expression of NLRP3 (NACHT, LRR, and
pyrin domain-containing protein 3) inﬂammasome which
resulted in decreased proteolytic cleavage of caspase-1.
Inactivation of caspase-1 by thymoquinone resulted in
the inhibition of IL-1b and IL-18. Thymoquinone also
inhibited NF-jB activity in mouse melanoma cells and
reactive oxygen species and the later in turn resulted in
the partial inactivation of NLRP3 inﬂammasome. The
authors suggested that, thymoquinone can be a potential
immunotherapeutic agent not only as an adjuvant therapy
for melanoma, but also, in the control and prevention of
metastatic melanoma (Ahmad et al., 2013).
8. Percutaneous absorption
The eﬀect of N. sativa oil on the percutaneous absorp-
tion of model lipophilic drug-carvedilol was investigated
using excised rat abdominal skin (Amin et al., 2008). N.
sativa oil in 5% v/v had high degree of enhancing perme-
ation as indicated by transdermal ﬂux, permeability coeﬃ-
cient and enhancement factor. Employing diﬀerential
scanning calorimetry, Fourier transform infrared andhistopathology, N. sativa oil in 5% v/v, was found to work
by extracting lipids from stratum corneum and by loosen-
ing the hydrogen bonds between ceramides with subse-
quent ﬂuidization of the lipid bilayer. The increased
permeability of the lipophilic drug-carvedilol was consid-
ered to be due to increased diﬀusivity through the stratum
corneum under the inﬂuence of N. sativa oil. It was postu-
lated that, the higher content of linoleic acid and other
unsaturated fatty acids in N. sativa oil was responsible
for the enhancement of in vitro percutaneous absorption
of the drug (Amin et al., 2010).
9. Cosmetic application
Using pH meter, corneometer, tewameter, methyl nicoti-
nate model of micro-inﬂammation in human skin, and tape
stripping of the stratum corneum, the in vivo and ex vivo
properties of emulsions with the seedcake extracts of N.
sativa have been evaluated (Amin et al., 2010). Emulsions
with Borago oﬃcinalis, and N. sativa seedcakes signiﬁ-
cantly reduced skin irritation and improved the skin hydra-
tion and epidermal barrier function as compared with
placebo. The authors suggested the potential use of seed-
cakes in anti-aging, moisturizing, mitigating, and protec-
tive cosmetics due to their antioxidant and
anti-inﬂammatory activities.10. Cutaneous side eﬀects
Contact dermatitis developed after the application of
ointment made from the N. sativa seed oil but it could have
been due to some impurity in the commercial black seed oil
(Zedlitz et al., 2002). Bullous drug eruption with
sub-epidermal detachment and necrosis of the epidermal
surface has been reported in a 53-year-old woman after
2 weeks of applying N. sativa oil to her skin and ingesting
it as well (Gelot et al., 2012).11. Conclusion
The published original research articles on the eﬀects of
N. sativa and its ingredients strongly indicate its pharmaco-
logical potential in dermatology. Standard methods of
drug development are needed to formulate topical therapy
for use in dermatology.Conﬂict of interest
None.
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